Examples of using Synflorix in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
If Synflorix is co-administered with other vaccines,
In a clinical study children received either Synflorix(N=603) or 7-valent Prevenar(N=203)
In Finland, Synflorix was introduced into NIP with a 2+1 schedule in infants(3,
Synflorix must not be used in children who have a severe fever, but it can be
The additional studies showed that Synflorix led to an increase in antibody production following booster vaccinations.
The adjusted effectiveness represents the percent reduction in IPD in the Synflorix vaccinated group compared to the unvaccinated group,
The children in this study were given either Synflorix or a comparator vaccine which was not active against S. pneumoniae and were followed up for an average of 30 months.
The immune responses elicited by Synflorix in previously unvaccinated older children were evaluated in three clinical studies.
The safety and efficacy of Synflorix in children over 5 years of age have not been established.
Another main study was carried out to determine whether Synflorix would prevent acute otitis media.
7F), Synflorix was effective in triggering the production of antibodies.
However, children who received 7-valent Prevenar for the primary series would not be primed against the additional serotypes contained in Synflorix 1, 5, 7F.
The children were followed up for an average of around two years to see how effective Synflorix was in preventing invasive disease.
before or immediately after Synflorix is given.
As for other vaccines administered intramuscularly, Synflorix should be given with caution to individuals with thrombocytopenia or any coagulation disorder
Efficacy of Synflorix against first episodes of likely bacterial Community Acquired Pneumonia(CAP) occurring from 2
For serotypes 1, 5 and 7F, the percentages of Synflorix vaccinees reaching an OPA titre 8 were respectively 65.7%, 90.9% and 99.6% after the primary vaccination course
In a clinical study, it has been demonstrated that Synflorix can be safely administered as a booster dose in the second year of life to children who had received 3 primary doses of 7-valent Prevenar.
In Brazil, Synflorix was introduced into the national immunisation programme(NIP)
In Quebec, Canada, Synflorix was introduced into the infant immunisation programme(2 primary doses to infants less than 6 months of age and a booster dose at 12 months) following 4.5 years